The global non fusion spinal devices market is predicted to register a CAGR of 4.8% over the forecast period, as per recent FMI analysis. The industry’s market valuation is anticipated to rise from US$ 4.37 billion in 2023 to US$ 6.99 billion by 2033 end. The non-fusion spinal devices industry is poised to attain a healthy pace …
Category Archives: Healthcare Trends
Systemic Lupus Erythematous SLE Drugs Market is expected to record a CAGR of 5% from 2022 to 2032
[250 Pages Report] Global systemic lupus erythematous drugs market growth is fast in North American region and is estimated to project remarkable CAGR growth throughout forecast period. In North America, the SLE is more prevalent among Hispanics, Asians, and Native Americans according to Centers for Disease Control and Prevention (CDC). The second largest and fastest growing global …
Colorectal Cancer Molecular Diagnostics Market a CAGR of 8% by 2022 to 2032
Future Market Insights (FMI) presents its new, comprehensive study on the global Colorectal Cancer Molecular Diagnostics market has a market value of US$ 2.35 billion in 2022 and is anticipated to reach US$ 5.07 billion by 2032, growing at an 8% CAGR. The market is expanding as a result of rising cancer incidence and advancements in diagnostic …
Continue reading “Colorectal Cancer Molecular Diagnostics Market a CAGR of 8% by 2022 to 2032”
Spatial Mass Spectrometry Market is expected to increase at a CAGR of around 15.3% from 2022 to 2032
The global Spatial Mass Spectrometry market is valued at US$ 224.1 Mn in 2021 and is expected to reach US$ 1.0 Bn by 2032, expanding at a CAGR of 15.3% between 2022 and 2032. According to Future Market Insights, a market research and competitive intelligence provider, global Spatial Mass Spectrometry consumption has increased at a CAGR of …
Nerve Monitoring Devices Market is projected to reach a valuation of US$ 1.7 Billion by 2026
The Nerve Monitoring Devices Market is for nerve monitoring devices is anticipated to grow at a CAGR of 6.1% over the course of the forecast period, from US$ 1.1 billion in 2021 to US$ 1.7 billion by 2026. With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an …
Brain Implants Market is anticipated to reach US$ 18 billion by 2032, at a CAGR of 12.3%
The global Brain Implants market demand is predicted to grow at a 12.3% CAGR to US$ 18 billion by 2032. According to GLOBOCAN 2020 statistics, there were approximately 308,102 cases of brain and nervous system cancer recorded globally in 2020. Trauma, malignant tumours, external decompression of intracranial pressure, and congenital malformations are all manifestations of …
Surgical Navigation System Market Growth 2022 to 2032 | By Medtronic, Stryker, GE Healthcare, Brainlab AG
During the projected period, the global Surgical Navigation System market demand is expected to develop at a compound yearly growth rate of 6.2%, reaching a value of US$ 1,700 million by 2030. Surgical Navigation Systems is a dependable technology that has been designed to make surgeries safer and less intrusive as compared to surgeries without …
Prophylactic HIV Drugs Market Forecast 2022 to 2032 | By Merck, Mylan NV, Cipla, Gilead Sciences, Genentech
In 2021, the global market for Prophylactic HIV Drugs is anticipated to be worth around US$ 30 billion. This demand is expected to develop at a compound annual growth rate (CAGR) of 4% between 2022 and 2032, with a value of more than US$ 40 billion by 2028. The rise in demand is attributable to …
Formulation Development Outsourcing Market Size 2022 to 2032 | By Recipharm Element, Intertek, Catalent
The Formulation Development Outsourcing market sales is estimated to be valued US$ 66.60 billion in 2032, up from US$ 33.23 billion in 2022, with a CAGR of 7.2% from 2022 to 2032. Higher research and development expenditures are expected to fuel demand for Formulation Development Outsourcing. Formulation Development Outsourcing services are widely used by small …
Direct-to-Consumer Genetic Testing Market is anticipated to reach US$ 4.0 Billion by 2032
As per Future Market Insights’ latest study, the Global Direct-to-Consumer Genetic Testing Market Size estimated to reach US$ 1.4 Billion by 2022 and is projected to exhibit a CAGR of 11.2% over the forecast period, with an estimated valuation of US$ 4.0 Billion in 2032. The Direct-to-Consumer Genetic Testing market is expected to grow at a steady pace due to increasing …